Analysis demonstrates detection limit of 13 pg/mL for carcinoembryonic antigen in cancer diagnostics, indicating enhanced sensitivity with terahertz technology.
An aptamer-linked terahertz metamaterial sensor (ALT-Meta sensor) is presented for the sensitive detection of Carcinoembryonic Antigen (CEA), a biomarker of cancer in humans. The ALT-Meta sensor incorporates two symmetric split-ring resonators within a single unit cell, which boasts an exceptionally high quality (Q) factor of 20.4. Leveraging the silico SELEX method, we obtained a highly specific CEA-targeting aptamer (Seq >571) that significantly amplifies the sensor's sensitivity while maintaining its remarkable specificity. Experimental results demonstrate that the ALT-Meta sensor exhibits a robust response to CEA concentrations ranging from 0.1 to 100 ng/mL, with a detection limit as low as 13 pg/mL, which is an order of magnitude lower than that of traditional antibody-based sensors. Its simplicity, stability, and cost-effectiveness make it a highly efficient platform for accurate CEA detection, advancing early cancer diagnostics.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: